Literature DB >> 25663790

Castleman's disease of the spleen.

Hee-Jeong Lee1, Ho-Jong Jeon1, Sang-Gon Park1, Chi-Young Park1.   

Abstract

Castleman's disease (CD) is a rare lymphoproliferative disorder of unknown etiology. Clinically, it occurs as a localized (unicentric) disease or as a systemic (multicentric) disease. Unicentric Castleman's disease (UCD) presents as a solitary mass and primarily affects the mediastinal, retroperitoneal, and cervical lymph nodes. In contrast to multicentric CD, which involves peripheral lymphadenopathy and numerous systemic symptoms, UCD is not typically associated with generalized symptoms. Three main distinct histologic variants are recognized: hyaline-vascular type, plasma cell type, and mixed type. Extranodal CD is rare. Specifically, UCD exclusively in the spleen is extremely rare, with only 2 cases described in the literature to date. Here, we describe an asymptomatic 75-year-old man with a 5.7 cm × 4.5 cm sized heterogenous enhanced mass located in the spleen. He underwent surgical resection for diagnosis and treatment. A pathologic examination indicated the hyaline-vascular type of CD. In this patient, the preoperative diagnosis was difficult to determine, and therefore, invasive procedures were required.

Entities:  

Keywords:  Castleman’s disease; Hyaline-vascular type; Spleen

Mesh:

Year:  2015        PMID: 25663790      PMCID: PMC4316113          DOI: 10.3748/wjg.v21.i5.1675

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Classic case of unicentric mixed-type Castleman's disease.

Authors:  Ravi Nagubandi; Yanhua Wang; Janice P Dutcher; Prakashchandra M Rao
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

2.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

Review 3.  Castleman's disease.

Authors:  M A Goldberg; S A Deluca
Journal:  Am Fam Physician       Date:  1989-09       Impact factor: 3.292

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

6.  Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

Authors:  G M Chronowski; C S Ha; R B Wilder; F Cabanillas; J Manning; J D Cox
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

7.  [A unifocal manifestation of Castleman's disease (angiofollicular lymphatic hyperplasia) in the spleen].

Authors:  C Kujat; C Müller-Leisse; P Lorbacher; R Seufert; S Falk; H J Stutte
Journal:  Rofo       Date:  1990-05

8.  Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion.

Authors:  Y Mori; N Nishimoto; M Ohno; R Inagi; P Dhepakson; K Amou; K Yoshizaki; K Yamanishi
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

9.  Multicentric giant lymph node hyperplasia.

Authors:  A R Gaba; R S Stein; D L Sweet; D Variakojis
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

10.  Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.

Authors:  Hesham M Amin; L Jeffrey Medeiros; John T Manning; Dan Jones
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more
  3 in total

1.  A retrospective study of 34 patients with unicentric and multicentric Castleman's disease: Experience from a single institution.

Authors:  Jin-Peng Jiang; Xiao-Fei Shen; Jun-Feng Du; Wen-Xian Guan
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

Review 2.  Laparoscopic treatment of abdominal unicentric castleman's disease: a case report and literature review.

Authors:  Umberto Bracale; Francesco Pacelli; Marco Milone; Umberto Marcello Bracale; Maurizio Sodo; Giovanni Merola; Teresa Troiani; Enrico Di Salvo
Journal:  BMC Surg       Date:  2017-04-12       Impact factor: 2.102

3.  Case Report: A rare case of primary hepatic Castleman's disease mimicking a liver tumor.

Authors:  Hong Chen; Xiaoxi Pang; Jie Li; Baixuan Xu; Yachao Liu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.